Baranzini SE - Search Results

1

Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis.

Kim K, Pröbstel AK, Baumann R, Dyckow J, Landefeld J, Kogl E, Madireddy L, Loudermilk R, Eggers EL, Singh S, Caillier SJ, Hauser SL, Cree BAC; UCSF MS-EPIC Team; Schirmer L, Wilson MR, Baranzini SE. Kim K, et al. Among authors: baranzini se. Brain. 2021 Mar 3;144(2):450-461. doi: 10.1093/brain/awaa421. Brain. 2021. PMID: 33374005 Free PMC article.

2

Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression.

Baranzini SE, Elfstrom C, Chang SY, Butunoi C, Murray R, Higuchi R, Oksenberg JR. Baranzini SE, et al. J Immunol. 2000 Dec 1;165(11):6576-82. doi: 10.4049/jimmunol.165.11.6576. J Immunol. 2000. PMID: 11086101

3

Multiple sclerosis: genomic rewards.

Oksenberg JR, Baranzini SE, Barcellos LF, Hauser SL. Oksenberg JR, et al. Among authors: baranzini se. J Neuroimmunol. 2001 Feb 15;113(2):171-84. doi: 10.1016/s0165-5728(00)00444-6. J Neuroimmunol. 2001. PMID: 11164900 Review.

4

New insights into the genetics of multiple sclerosis.

Baranzini SE, Oksenberg JR, Hauser SL. Baranzini SE, et al. J Rehabil Res Dev. 2002 Mar-Apr;39(2):201-9. J Rehabil Res Dev. 2002. PMID: 12051464 Free article. Review.

5

The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta.

Villoslada P, Barcellos LF, Rio J, Begovich AB, Tintore M, Sastre-Garriga J, Baranzini SE, Casquero P, Hauser SL, Montalban X, Oksenberg JR. Villoslada P, et al. Among authors: baranzini se. J Neuroimmunol. 2002 Sep;130(1-2):194-201. doi: 10.1016/s0165-5728(02)00215-1. J Neuroimmunol. 2002. PMID: 12225902 Clinical Trial.

6

Large-scale gene-expression studies and the challenge of multiple sclerosis.

Baranzini SE, Hauser SL. Baranzini SE, et al. Genome Biol. 2002 Sep 16;3(10):reviews1027. doi: 10.1186/gb-2002-3-10-reviews1027. Epub 2002 Sep 16. Genome Biol. 2002. PMID: 12372148 Free PMC article. Review.

7

Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis.

Sriram U, Barcellos LF, Villoslada P, Rio J, Baranzini SE, Caillier S, Stillman A, Hauser SL, Montalban X, Oksenberg JR. Sriram U, et al. Among authors: baranzini se. Genes Immun. 2003 Mar;4(2):147-52. doi: 10.1038/sj.gene.6363946. Genes Immun. 2003. PMID: 12618863 Clinical Trial.

8

Osteopontin polymorphisms and disease course in multiple sclerosis.

Caillier S, Barcellos LF, Baranzini SE, Swerdlin A, Lincoln RR, Steinman L, Martin E, Haines JL, Pericak-Vance M, Hauser SL, Oksenberg JR; Multiple Sclerosis Genetics Group. Caillier S, et al. Among authors: baranzini se. Genes Immun. 2003 Jun;4(4):312-5. doi: 10.1038/sj.gene.6363952. Genes Immun. 2003. PMID: 12761568

9

Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.

Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, Lincoln RR, Swerdlin A, Mignot E, Lin L, Goodin D, Erlich HA, Schmidt S, Thomson G, Reich DE, Pericak-Vance MA, Haines JL, Hauser SL. Oksenberg JR, et al. Among authors: baranzini se. Am J Hum Genet. 2004 Jan;74(1):160-7. doi: 10.1086/380997. Epub 2003 Dec 10. Am J Hum Genet. 2004. PMID: 14669136 Free PMC article.

10

Transcription-based prediction of response to IFNbeta using supervised computational methods.

Baranzini SE, Mousavi P, Rio J, Caillier SJ, Stillman A, Villoslada P, Wyatt MM, Comabella M, Greller LD, Somogyi R, Montalban X, Oksenberg JR. Baranzini SE, et al. PLoS Biol. 2005 Jan;3(1):e2. doi: 10.1371/journal.pbio.0030002. Epub 2004 Dec 28. PLoS Biol. 2005. PMID: 15630474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page